Related Experiment Video

Updated: Jun 29, 2025

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

6.9K

Response to: Correspondence on 'EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update'

Bernhard Hellmich1, David Jayne2

  • 1Department of Internal Medicine, Rheumatology, Pulmonology, Nephrology and Diabetology, Medius Kliniken, University of Tübingen, Kirchheim-Teck, Germany b.hellmich@medius-kliniken.de.

Annals of the Rheumatic Diseases
|April 3, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Patient Reported Outcome MeasuresSystemic vasculitisTherapeutics

More Related Videos

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

134.7K
Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

35.9K

Related Experiment Videos

Last Updated: Jun 29, 2025

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

6.9K
Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

134.7K
Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

35.9K

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
Autoimmune Disorders01:29

Autoimmune Disorders

430
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
430

Articles linked to this work by shared authors, journal, and citation graph.

Evidence-based guidelines for the diagnosis and management of adult-onset IgA vasculitis.

Nature reviews. Rheumatology·2026

Large Vessel Vasculitis Revisited: Mechanistic Insights and Advances in Diagnosis and Management.

Journal of the American Heart Association·2026

Anifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus Nephritis.

Clinical pharmacology and therapeutics·2026

Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoids.

Nature reviews. Rheumatology·2026

Evaluation of the Long-Term Safety of Avacopan in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the Real World (AvacoStar): Protocol for a Noninterventional Prospective Cohort Study.

JMIR research protocols·2026

Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis With Polyangiitis: Findings From a Large European Cohort.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Multiomics landscape of systemic sclerosis: from autoantibody-positivity to established disease.

Annals of the rheumatic diseases·2026

IgG4-related disease is not associated with an increased incidence of malignancy in a large, single-centre cohort.

Annals of the rheumatic diseases·2026

Early arthritis signs and symptoms revisited-is synovitis what we are assessing?

Annals of the rheumatic diseases·2026

Preclinical and clinical outcomes in patients with high rheumatoid factor levels treated with TNF inhibitors:a systematic review.

Annals of the rheumatic diseases·2026

Immune reset in rheumatic autoimmune disease: from a tantalising metaphor to a measurable therapeutic state.

Annals of the rheumatic diseases·2026

DNA methylation signatures distinguish gout from asymptomatic hyperuricaemia and converge with genetic risk at immune-metabolic loci.

Annals of the rheumatic diseases·2026

Vascular norepinephrine responsiveness index for early risk stratification in emergency department septic shock: a real-world cohort study from a Latin American sepsis code registry.

Frontiers in medicine·2026

Associations of metabolic dysfunction-associated steatotic liver disease and significant fibrosis phenotypes with glomerular hyperfiltration defined by indexed eGFR.

Frontiers in nutrition·2026

Non-invasive assessment of estimated glomerular filtration rate using lens autofluorescence in a population without chronic kidney disease.

Frontiers in medicine·2026

Dynamic machine-learning model for early prediction of intraoperative hypotension using 5-minute perioperative time-series data: a multicenter retrospective study.

Frontiers in medicine·2026

Associated factors and predictive modeling of deep vein thrombosis in stroke patients undergoing rehabilitation.

Frontiers in neurology·2026

Interpretable machine learning models to predict venous thromboembolism in sepsis patients with type 2 diabetes mellitus.

Frontiers in endocrinology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us